Non-invasive detection of EGFR and TP53 mutations through the combination of plasma, urine and sputum in advanced non-small cell lung cancer

The sensitivity and utility of liquid biopsy in clinical practice requires some improvement. The aim of the present study was to improve the detection of epidermal growth factor (EGFR) and cellular tumor antigen p53 (TP53) mutations in liquid biopsies from patients with advanced non-small cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhen, Yang, Zhen, Li, Chun-Sun, Zhao, Wei, Liang, Zhi-Xin, Dai, Yu, Zeng, Jing, Zhu, Qiang, Miao, Kai-Ling, Cui, Dong-Hua, Chen, Liang-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732959/
https://www.ncbi.nlm.nih.gov/pubmed/31516572
http://dx.doi.org/10.3892/ol.2019.10726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732959/
https://www.ncbi.nlm.nih.gov/pubmed/31516572
http://dx.doi.org/10.3892/ol.2019.10726

Ejemplares similares